435 related articles for article (PubMed ID: 30621731)
1. Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.
Raimondo S; Saieva L; Vicario E; Pucci M; Toscani D; Manno M; Raccosta S; Giuliani N; Alessandro R
J Hematol Oncol; 2019 Jan; 12(1):2. PubMed ID: 30621731
[TBL] [Abstract][Full Text] [Related]
2. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.
Taverna S; Pucci M; Giallombardo M; Di Bella MA; Santarpia M; Reclusa P; Gil-Bazo I; Rolfo C; Alessandro R
Sci Rep; 2017 Jun; 7(1):3170. PubMed ID: 28600504
[TBL] [Abstract][Full Text] [Related]
3. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor.
Corrado C; Saieva L; Raimondo S; Santoro A; De Leo G; Alessandro R
J Cell Mol Med; 2016 Oct; 20(10):1829-39. PubMed ID: 27196940
[TBL] [Abstract][Full Text] [Related]
4. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation.
Raimondi L; De Luca A; Amodio N; Manno M; Raccosta S; Taverna S; Bellavia D; Naselli F; Fontana S; Schillaci O; Giardino R; Fini M; Tassone P; Santoro A; De Leo G; Giavaresi G; Alessandro R
Oncotarget; 2015 May; 6(15):13772-89. PubMed ID: 25944696
[TBL] [Abstract][Full Text] [Related]
5. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts.
Faict S; Muller J; De Veirman K; De Bruyne E; Maes K; Vrancken L; Heusschen R; De Raeve H; Schots R; Vanderkerken K; Caers J; Menu E
Blood Cancer J; 2018 Nov; 8(11):105. PubMed ID: 30409995
[TBL] [Abstract][Full Text] [Related]
6. Amphiregulin exosomes increase cancer cell invasion.
Higginbotham JN; Demory Beckler M; Gephart JD; Franklin JL; Bogatcheva G; Kremers GJ; Piston DW; Ayers GD; McConnell RE; Tyska MJ; Coffey RJ
Curr Biol; 2011 May; 21(9):779-86. PubMed ID: 21514161
[TBL] [Abstract][Full Text] [Related]
7. Osteoblast-specific overexpression of amphiregulin leads to transient increase in femoral cancellous bone mass in mice.
Vaidya M; Lehner D; Handschuh S; Jay FF; Erben RG; Schneider MR
Bone; 2015 Dec; 81():36-46. PubMed ID: 26103093
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.
Gilmore JL; Gonterman RM; Menon K; Lorch G; Riese DJ; Robling A; Foley J
Mol Cancer Res; 2009 Oct; 7(10):1714-28. PubMed ID: 19825997
[TBL] [Abstract][Full Text] [Related]
9. Bone Marrow CD11c+ Cell-Derived Amphiregulin Promotes Pulmonary Fibrosis.
Ding L; Liu T; Wu Z; Hu B; Nakashima T; Ullenbruch M; Gonzalez De Los Santos F; Phan SH
J Immunol; 2016 Jul; 197(1):303-12. PubMed ID: 27206766
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2.
Yen CH; Hsu CM; Hsiao SY; Hsiao HH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937821
[TBL] [Abstract][Full Text] [Related]
11. EGF, TGF-
Kamentseva RS; Kharchenko MV; Gabdrahmanova GV; Kotov MA; Kosheverova VV; Kornilova ES
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686213
[TBL] [Abstract][Full Text] [Related]
12. Prenatal smoke exposure dysregulates lung epithelial cell differentiation in mouse offspring: role for AREG-induced EGFR signaling.
Lkhagvadorj K; Zeng Z; Song J; Reinders-Luinge M; Kooistra W; Song S; Krauss-Etschmann S; Melgert BN; Cao J; Hylkema MN
Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L742-L751. PubMed ID: 32783621
[TBL] [Abstract][Full Text] [Related]
13. Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma-Induced Osteolysis and Reduces Overall Survival.
Lo CH; Shay G; McGuire JJ; Li T; Shain KH; Choi JY; Fuerst R; Roush WR; Knapinska AM; Fields GB; Lynch CC
Cancer Res; 2021 May; 81(9):2415-2428. PubMed ID: 33526510
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer.
Bormann F; Stinzing S; Tierling S; Morkel M; Markelova MR; Walter J; Weichert W; Roßner F; Kuhn N; Perner J; Dietz J; Ispasanie S; Dietel M; Schäfer R; Heinemann V; Sers C
Int J Cancer; 2019 Feb; 144(3):569-581. PubMed ID: 30252132
[TBL] [Abstract][Full Text] [Related]
15. Amphiregulin/epidermal growth factor receptor/hypoxia-inducible factor-1α pathway regulates T helper 9 and T cytotoxic 9 cell response in adult patients with infectious mononucleosis.
Li Y; Li L; Zhang W; Gao Y
Biomol Biomed; 2023 Feb; 23(1):63-72. PubMed ID: 36154925
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin potentiates airway inflammation and mucus hypersecretion induced by urban particulate matter via the EGFR-PI3Kα-AKT/ERK pathway.
Wang J; Zhu M; Wang L; Chen C; Song Y
Cell Signal; 2019 Jan; 53():122-131. PubMed ID: 30291869
[TBL] [Abstract][Full Text] [Related]
17. Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells.
Mahtouk K; Hose D; Rème T; De Vos J; Jourdan M; Moreaux J; Fiol G; Raab M; Jourdan E; Grau V; Moos M; Goldschmidt H; Baudard M; Rossi JF; Cremer FW; Klein B
Oncogene; 2005 May; 24(21):3512-24. PubMed ID: 15735670
[TBL] [Abstract][Full Text] [Related]
18. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.
Roccaro AM; Sacco A; Maiso P; Azab AK; Tai YT; Reagan M; Azab F; Flores LM; Campigotto F; Weller E; Anderson KC; Scadden DT; Ghobrial IM
J Clin Invest; 2013 Apr; 123(4):1542-55. PubMed ID: 23454749
[TBL] [Abstract][Full Text] [Related]
19. An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.
Carvalho S; Lindzen M; Lauriola M; Shirazi N; Sinha S; Abdul-Hai A; Levanon K; Korach J; Barshack I; Cohen Y; Onn A; Mills G; Yarden Y
Oncogene; 2016 Jan; 35(4):438-47. PubMed ID: 25915843
[TBL] [Abstract][Full Text] [Related]
20. A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.
Vallet S; Pozzi S; Patel K; Vaghela N; Fulciniti MT; Veiby P; Hideshima T; Santo L; Cirstea D; Scadden DT; Anderson KC; Raje N
Leukemia; 2011 Jul; 25(7):1174-81. PubMed ID: 21403648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
